Skip to main content

Table 2 Guideline appraisal

From: Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument

Guideline

Domain #1: scope and purpose

Domain #2: stakeholder involvement

Domain #3: rigor of development

Domain #4: clarity of presentation

Domain #5: applicability

Domain #6: editorial independence

Overall assessment

Recommendation

Alberta Health Services

61%

35%

83%

63%

0%

75%

58%

Recommended

American Cancer Society

33%

6%

7%

46%

4%

8%

8%

Not recommended

American Society of Clinical Oncology

44%

36%

15%

75%

23%

46%

42%

Not recommended

Association of Community Cancer Centers

19%

36%

2%

75%

4%

0%

17%

Not recommended

Commission on Cancer

19%

33%

12%

88%

19%

0%

33%

Not recommended

Comprehensive Cancer Center of the Netherlands

69%

75%

56%

96%

38%

42%

67%

Recommended

International Myeloma Foundation

56%

42%

17%

63%

21%

96%

42%

Not recommended

Institute of Medicine

22%

42%

12%

92%

38%

38%

50%

Not recommended

LIVESTRONG

33%

22%

10%

96%

31%

0%

33%

Not recommended

National Breast and Ovarian Cancer Centre

28%

58%

26%

46%

0%

63%

33%

Not recommended

National Comprehensive Cancer Network

72%

58%

26%

67%

31%

42%

50%

Not recommended

National Coalition for Cancer Survivorship/Institute of Medicine/Lance Armstrong Foundation/National Cancer Institute

92%

61%

18%

63%

52%

0%

58%

Recommended

National Cancer Institute Community Cancer Centers Program

56%

42%

17%

88%

40%

29%

58%

Recommended

National Collaborating Centre for Cancer

19%

86%

69%

79%

40%

29%

58%

Recommended

President’s Cancer Panel

11%

92%

7%

92%

15%

0%

25%

Not recommended

National Health Service

31%

39%

5%

42%

0%

0%

25%

Not recommended